首页 > 市场调查报告书 > 製药

再生医学

市场调查报告书

商品编码

1891147

再生医学市场：按组织类型、应用、最终用户和地区划分

Regenerative Therapies Market, By Tissue Type, By Application type, By End user, By Geography

出版日期: 2025年11月07日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年再生医学市场规模预计为 1,252.5 亿美元，预计到 2032 年将达到 3,476.3 亿美元，2025 年至 2032 年的复合年增长率为 15.7%。

分析范围		分析详情
基准年	2024	市场规模（2025 年）	1252.5亿美元
效能数据	2020-2024	预测期	2025-2032
预测期（2025-2032 年）复合年增长率	15.70%	预计金额（2032 年）	3476.3亿美元

再生医学是一种以干细胞为基础的治疗方法，也是医学领域发展最快的领域之一。老龄化和损伤会导致人体难以获得维持正常功能所需的最佳干细胞数量。再生医学的目标是增强人体自身的自然癒合能力，并满足患者的需求。整形外科是再生医学的一个分支，它透过刺激肌肉骨骼系统中的细胞再生来利用人体自身的癒合过程。 Histogen是整形外科再生医学产品的生产商之一。其生产的人类细胞外基质（hECM）具有抗发炎和血管生成特性，能够促进损伤部位的干细胞生长，进而诱导组织再生。

市场动态

由于对修復和再生受损组织和器官的创新疗法的需求不断增长，再生医学市场正经历快速扩张。干细胞疗法、组织工程和基因疗法的进步塑造了市场动态，并推动了市场成长。儘管面临成本和监管复杂性方面的挑战，但持续的技术进步和研发投入的增加正在推动市场向前发展。随着人们意识的提高和临床证据的积累，再生医学市场有望透过提供创新解决方案和改善患者预后，从而改变医疗保健产业。

全球再生医学市场阻碍因素

组织工程和生物医学工程领域缺乏标准化指南预计将阻碍全球再生医学市场的成长。此外，由于临床试验週期过长导致产品上市延迟，预计也会抑制市场成长。

本报告的主要特点

本报告对全球再生医学市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和复合年增长率。
它还重点介绍了各个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
它还提供了有关市场驱动因素、限制因素和机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的关键见解。
该报告根据公司概况、产品系列、主要亮点、财务表现和策略等参数，对全球再生医学市场的主要企业进行了分析。
本报告提供的见解将使负责人和企业经营团队能够就未来的产品发布、合作关係、市场扩张和行销策略做出明智的决策。
《全球再生医学市场》报告面向该行业的各类相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过各种用于分析全球再生医学市场的策略矩阵，更轻鬆地做出决策。

公司简介
- Shire Pharmaceuticals
- Kinetic Concepts, Inc.
- Mesoblast Ltd.
- Metcela Inc.
- Nuo Therapeutics（Cytomedix Inc.）
- Integra LifeSciences
- Advanced Cell Technology, Inc.
- BioStem Life Sciences
- Akron Biotechnology, LLC
- Organovo Holdings Inc.
- Orgenesis Inc.
- Pluristem Therapeutics Inc.
- Genzyme
- Athersys, Inc.
- RenovaCare, Inc.
- Cytori Therapeutics, Inc.

第九章各节

参考
分析方法

简介目录

Product Code: CMI3712

Regenerative Therapies Market is estimated to be valued at USD 125.25 Bn in 2025 and is expected to reach USD 347.63 Bn by 2032, growing at a compound annual growth rate (CAGR) of 15.7% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 125.25 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	15.70%	2032 Value Projection:	USD 347.63 Bn

Regenerative medicine is one the fastest emerging fields of medicine, as it adopts stem cells for treatment. Increasing age or injury, makes it difficult to provide the optimum amount of stem cells that are needed to maintain the normal function. The goal of regenerative medicine is to amplify this natural repair system to keep pace with the demands of the patients. Orthopedics is one of the fields of regenerative medicine, which adopts natural healing process by stimulating regeneration of cells in the musculoskeletal system. Histogen Inc. is one of the manufacturer of orthopedic regenerative medicine and its product Human Extracellular matrix (hECM) is anti-inflammatory, angiogenic, and can stimulate growth of stem cells in damaged areas to induce tissue regeneration.

Market Dynamics

The regenerative therapy market is witnessing rapid expansion due to the increasing demand for innovative treatments that can restore and regenerate damaged tissues and organs. Market dynamics are being shaped by advancements in stem cell therapies, tissue engineering, and gene therapy, which are driving the market's growth. Despite challenges related to cost and regulatory complexities, continuous technological advancements and growing investments in research and development are driving the market forward. As awareness grows and clinical evidence accumulates, the regenerative therapy market is poised to transform healthcare by offering transformative solutions and improving patient outcomes.

Restraints of the Global Regenerative Therapies Market

Lack of standardized guidelines on tissue and bio-medical engineering is expected to hinder growth of the global regenerative therapies market. Moreover, lengthy clinical trials leading to delayed entry of products in the market is expected to restrain growth of the market.

Key features of the study

This report provides in-depth analysis of the global regenerative therapies market and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period 2025-2032, considering 2024, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global regenerative therapies market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Shire Pharmaceuticals, Kinetic Concepts, Inc., Mesoblast Ltd., Metcela Inc., Nuo Therapeutics (Cytomedix Inc.), Integra LifeSciences, Advanced Cell Technology Inc., BioStem Life Sciences,Akron Biotechnology, LLC, Organovo Holdings Inc., Orgenesis Inc., Pluristem Therapeutics Inc., Genzyme, Athersys, Inc., RenovaCare, Inc., Cytori Therapeutics, Inc.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global regenerative therapies market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Market Segmentation

Global Regenerative Therapies Market, By Tissue Type
- Allograft
- Xenograft
- Alloplast
Global Regenerative Therapies Market, By Application
- Soft Tissue Repair
- Cardiovascular
- Dental
- Orthopedic
- CNS disease treatment
- Others
Global Regenerative Therapies Market, By End User
- Hospitals
- Ambulatory Surgical Centers
- Educational Institutes
Global Regenerative Therapies Market, By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- Central Africa
- South Africa
- North Africa
Company Profiles
- Shire Pharmaceuticals
- Kinetic Concepts, Inc.
- Mesoblast Ltd.
- Metcela Inc.
- Nuo Therapeutics (Cytomedix Inc.)
- Integra LifeSciences
- Advanced Cell Technology, Inc.
- BioStem Life Sciences
- Akron Biotechnology, LLC
- Organovo Holdings Inc.
- Orgenesis Inc.
- Pluristem Therapeutics Inc.
- Genzyme
- Athersys, Inc.
- RenovaCare, Inc.
- Cytori Therapeutics, Inc.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Tissue Type
- Market Snippet, By Application
- Market Snippet, By End User
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Key Developments
Regulatory Scenario
PEST Analysis

4. Global Regenerative Therapies Market, By Tissue Type, 2020-2032(US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032(%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Allograft
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Xenograft
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
Alloplast
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends

5. Global Regenerative Therapies Market, By Application, 2020-2032(US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032(%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Soft Tissue Repair
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Dental
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Orthopedic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
CNS disease treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)

6. Global Regenerative Therapies Market, By End User, 2020-2032(US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032(%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Educational Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)

7. Global Regenerative Therapies Market, By Regions, 2020-2032(US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032(%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
North Africa
Central Africa
South Africa

8. Competitive Landscape

Company Profiles
- Shire Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Kinetic Concepts, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Mesoblast Ltd.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Metcela Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Nuo Therapeutics (Cytomedix Inc.)
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Integra LifeSciences
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Advanced Cell Technology, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- BioStem Life Sciences
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Akron Biotechnology, LLC
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Organovo Holdings Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Orgenesis Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Pluristem Therapeutics Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Genzyme
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Athersys, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- RenovaCare, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Cytori Therapeutics, Inc.
  - Company Overview
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies

9. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

再生医学市场：按组织类型、应用、最终用户和地区划分

Regenerative Therapies Market, By Tissue Type, By Application type, By End user, By Geography

市场动态

目录

第一章分析目标和先决条件

第二章市场展望

第三章：市场动态、监理及趋势分析

第四章全球再生医学市场（依组织类型划分）（2020-2032 年）

第五章全球再生医学市场依应用领域划分（2020-2032 年）

第六章全球再生医学市场（按最终用户划分）（2020-2032 年）

第七章全球再生医学市场（按地区划分）（2020-2032 年）

第八章竞争情势